Last reviewed · How we verify
Corticosteroid vs. Dextrose
At a glance
| Generic name | Corticosteroid vs. Dextrose |
|---|---|
| Also known as | Triamcinolone injections versus 5% dextrose |
| Sponsor | University Medical Centre Ljubljana |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) (PHASE1, PHASE2)
- Dextrose, Corticosteroids and Surgical Release in Carpal Tunnel Syndrome (NA)
- Caudal Corticosteroid vs. Dextrose Injection for Lumbosacral Radicular Pain. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Corticosteroid vs. Dextrose CI brief — competitive landscape report
- Corticosteroid vs. Dextrose updates RSS · CI watch RSS
- University Medical Centre Ljubljana portfolio CI